Total Liabilities: The total value of all possible claims against the corporation.
Castle Biosciences, Inc. (CSTL) had Total Liabilities of $91.15M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$103.55M |
|
$-2.06M |
|
$23.70M |
|
$79.85M |
|
$106.62M |
|
$-3.07M |
|
$1.38M |
|
$-1.69M |
|
$-1.69M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-3.07M |
|
$0.61M |
|
30.40M |
|
30.40M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$341.10M |
|
$104.68M |
|
$220.08M |
|
$561.18M |
|
$56.51M |
|
$7.42M |
|
$34.64M |
|
|
Total Liabilities |
$91.15M |
$470.03M |
|
$374.93M |
|
$470.03M |
|
30.51M |
|
| Cash Flow Statement Financials | |
$-6.93M |
|
$-41.77M |
|
$-5.92M |
|
$116.73M |
|
$62.12M |
|
$-54.61M |
|
$21.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.04 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
77.11% |
|
-2.96% |
|
-2.96% |
|
-- |
|
-1.63% |
|
-1.99% |
|
$-28.02M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
2.24 |
|
2.14 |
|
42.02 |
|
-0.44% |
|
-0.55% |
|
-0.37% |
|
-0.43% |
|
$15.41 |
|
$-0.92 |
|
$-0.23 |
|